Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Proceedings of the inaugural Dark Genome Symposium: November 2022

    In November 2022 the first Dark Genome Symposium was held in Boston, USA. The meeting was hosted by Rome Therapeutics and Enara Bio, two biotechnology companies working on translating our growing understanding...

    Jef D. Boeke, Kathleen H. Burns, Katherine B. Chiappinelli, Marie Classon in Mobile DNA (2023)

  2. Article

    SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers

    Adult liver malignancies, including intrahepatic cholangiocarcinoma and hepatocellular carcinoma, are the second leading cause of cancer-related deaths worldwide. Most individuals are treated with either combi...

    Lei Shi, William Shen, Mindy I. Davis, Ke Kong, Phuong Vu, Supriya K. Saha in Nature Cancer (2023)

  3. No Access

    Article

    Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

    Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal and treatment-refractory cancer. Molecular stratification in pancreatic cancer remains rudimentary and does not yet inform clinical management or ther...

    William L. Hwang, Karthik A. Jagadeesh, Jimmy A. Guo, Hannah I. Hoffman in Nature Genetics (2022)

  4. No Access

    Article

    Selective targeting of MYC mRNA by stabilized antisense oligonucleotides

    MYC is a prolific proto-oncogene driving the malignant behaviors of numerous common cancers, yet potent and selective cell-permeable inhibitors of MYC remain elusive. In order to ultimately realize the goal of...

    Taylor Gill, Haichuan Wang, Raj Bandaru, Matthew Lawlor, Chenyue Lu in Oncogene (2021)

  5. No Access

    Article

    Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial

    Overcoming intrinsic resistance to immune checkpoint blockade for microsatellite stable (MSS) colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) remains challenging. We conducted a single-arm,...

    Aparna R. Parikh, Annamaria Szabolcs, Jill N. Allen, Jeffrey W. Clark in Nature Cancer (2021)

  6. No Access

    Article

    Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy

    Dynamic survival data based on time already survived are lacking for resected borderline resectable/locally advanced (BR/LA) pancreatic ductal adenocarcinoma (PDAC) patients who received total neoadjuvant ther...

    Theodoros Michelakos, Yurie Sekigami in Journal of Gastrointestinal Surgery (2021)

  7. Article

    Open Access

    Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection

    The relationship of SARS-CoV-2 pulmonary infection and severity of disease is not fully understood. Here we show analysis of autopsy specimens from 24 patients who succumbed to SARS-CoV-2 infection using a com...

    Niyati Desai, Azfar Neyaz, Annamaria Szabolcs, Angela R. Shih in Nature Communications (2020)

  8. Article

    Open Access

    HIF1A signaling selectively supports proliferation of breast cancer in the brain

    Blood-borne metastasis to the brain is a major complication of breast cancer, but cellular pathways that enable cancer cells to selectively grow in the brain microenvironment are poorly understood. We find tha...

    Richard Y. Ebright, Marcus A. Zachariah, Douglas S. Micalizzi in Nature Communications (2020)

  9. Article

    Open Access

    Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target

    Pancreatic ductal adenocarcinoma (PDAC) lethality is due to metastatic dissemination. Characterization of rare, heterogeneous circulating tumor cells (CTCs) can provide insight into metastasis and guide develo...

    Joseph W. Franses, Julia Philipp, Pavlos Missios, Irun Bhan in Nature Communications (2020)

  10. Article

    Open Access

    GlioM&M: Web-based tool for studying circulating and infiltrating monocytes and macrophages in glioma

    Monocytes, macrophages and microglia make up a large part of the glioma environment and have an important role in maintaining and propagating glioma progression. Targeting these cells to inhibit their tumor-pr...

    Erik R. Abels, Sybren L. N. Maas, Eric Tai, David T. Ting in Scientific Reports (2020)

  11. Article

    Open Access

    Glioblastoma hijacks microglial gene expression to support tumor growth

    Glioblastomas are the most common and lethal primary brain tumors. Microglia, the resident immune cells of the brain, survey their environment and respond to pathogens, toxins, and tumors. Glioblastoma cells c...

    Sybren L. N. Maas, Erik R. Abels, Lieke L. Van De Haar in Journal of Neuroinflammation (2020)

  12. Article

    Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina, Lipika Goyal in Nature Medicine (2019)

  13. No Access

    Article

    Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

    During cancer therapy, tumor heterogeneity can drive the evolution of multiple tumor subclones harboring unique resistance mechanisms in an individual patient13. Previous case reports and small case series have ...

    Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina, Lipika Goyal in Nature Medicine (2019)

  14. Article

    Open Access

    A tumor-specific endogenous repetitive element is induced by herpesviruses

    Tandem satellite repeats account for 3% of the human genome. One of them, Human Satellite II (HSATII), is highly expressed in several epithelial cancers and cancer cell lines. Here we report an acute induction...

    Maciej T. Nogalski, Alexander Solovyov, Anupriya S. Kulkarni in Nature Communications (2019)

  15. No Access

    Chapter

    Liquid Biopsy in Hepatocellular Carcinoma

    Solid tumors release a variety of cellular components into the bloodstream that can be sampled by liquid biopsy. These blood-borne biomarkers include circulating tumor cells, exosomes, cell-free DNA, and cell-...

    Irun Bhan, Daniel A. Haber, Raymond T. Chung, David T. Ting in Hepatocellular Carcinoma (2019)

  16. Article

    Open Access

    Relationship between hepatocellular carcinoma circulating tumor cells and tumor volume

    Microfluidic platforms have demonstrated the ability to isolate rare circulating tumor cells from a wide variety of cancers. Our group has recently shown the ability to isolate circulating tumor cells (CTCs) f...

    Rahmi Oklu, Rahul Sheth, Hassan Albadawi, Irun Bhan in Cancer Convergence (2018)

  17. Article

    Open Access

    Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles

    Extracellular vesicles (EVs) carry RNA, DNA, proteins, and lipids. Specifically, tumor-derived EVs have the potential to be utilized as disease-specific biomarkers. However, a lack of methods to isolate tumor-...

    Eduardo Reátegui, Kristan E. van der Vos, Charles P. Lai in Nature Communications (2018)

  18. Article

    Open Access

    Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells

    Precise rare-cell technologies require the blood to be processed immediately or be stabilized with fixatives. Such restrictions limit the translation of circulating tumor cell (CTC)-based liquid biopsy assays ...

    Keith H. K. Wong, Shannon N. Tessier, David T. Miyamoto in Nature Communications (2017)

  19. Article

    Open Access

    Introducing cancer convergence

    Krastan B. Blagoev, David T. Ting, Herbert Levine, Yvonne Saenger in Cancer Convergence (2017)

  20. Article

    Open Access

    Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination

    Metastasis-competent circulating tumour cells (CTCs) experience oxidative stress in the bloodstream, but their survival mechanisms are not well defined. Here, comparing single-cell RNA-Seq profiles of CTCs fro...

    Yu Zheng, David T. Miyamoto, Ben S. Wittner, James P. Sullivan in Nature Communications (2017)

previous disabled Page of 2